183 related articles for article (PubMed ID: 12469191)
61. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
62. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
[TBL] [Abstract][Full Text] [Related]
63. Overexpression and mutation of p53 in epithelial ovarian cancer.
Marks JR; Davidoff AM; Kerns BJ; Humphrey PA; Pence JC; Dodge RK; Clarke-Pearson DL; Iglehart JD; Bast RC; Berchuck A
Cancer Res; 1991 Jun; 51(11):2979-84. PubMed ID: 2032235
[TBL] [Abstract][Full Text] [Related]
64. [Relation between COX-2 protein expression and biologic behavior of ovarian carcinoma].
Tang LX; Wang M; Ma JW
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):261-3. PubMed ID: 12839690
[TBL] [Abstract][Full Text] [Related]
65. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.
Maitra A; Ashfaq R; Gunn CR; Rahman A; Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Wilentz RE
Am J Clin Pathol; 2002 Aug; 118(2):194-201. PubMed ID: 12162677
[TBL] [Abstract][Full Text] [Related]
66. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
Zang T; Sun F; Li Y
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
[TBL] [Abstract][Full Text] [Related]
67. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs.
Ermert L; Ermert M; Goppelt-Struebe M; Walmrath D; Grimminger F; Steudel W; Ghofrani HA; Homberger C; Duncker H; Seeger W
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):479-88. PubMed ID: 9533935
[TBL] [Abstract][Full Text] [Related]
68. Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms.
Parrett ML; Abou-Issa HM; Alshafie G; Ross MS; Harris RE; Robertson FM
Anticancer Res; 1999; 19(6B):5079-85. PubMed ID: 10697514
[TBL] [Abstract][Full Text] [Related]
69. Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas.
Gubbay O; Guo W; Rae MT; Niven D; Langdon SP; Hillier SG
Br J Cancer; 2005 May; 92(10):1927-33. PubMed ID: 15870720
[TBL] [Abstract][Full Text] [Related]
70. [Overexpression of COX-2 and a potential clinical application of its inhibitors in lung cancer].
Hida T
Nihon Rinsho; 2004 Jul; 62(7):1357-62. PubMed ID: 15283156
[TBL] [Abstract][Full Text] [Related]
71. Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.
Li HL; Sun BZ; Ma FC
World J Gastroenterol; 2004 Jul; 10(13):1862-6. PubMed ID: 15222024
[TBL] [Abstract][Full Text] [Related]
72. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.
Denkert C; Weichert W; Pest S; Koch I; Licht D; Köbel M; Reles A; Sehouli J; Dietel M; Hauptmann S
Cancer Res; 2004 Jan; 64(1):189-95. PubMed ID: 14729623
[TBL] [Abstract][Full Text] [Related]
73. [Cyclooxygenase-2 expression in esophageal cancer cells and induction by mitomycin C].
Zhuang ZH; Wang LD; Tsao SW; Cheung LM; Feng HC; Yang T; Qin YR; Wang CD; Chen ZZ; Liu B
Zhonghua Nei Ke Za Zhi; 2003 Oct; 42(10):701-4. PubMed ID: 14633464
[TBL] [Abstract][Full Text] [Related]
74. Expression of COX-2 in stomach cancers and its relation to their biological features.
Han SL; Tang HJ; Hua YW; Ji SQ; Lin DX
Dig Surg; 2003; 20(2):107-14. PubMed ID: 12686777
[TBL] [Abstract][Full Text] [Related]
75. [Expression of cyclooxygenase-2 and p53 and their correlation in carcinoma of larynx].
Lu H; Gong S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):421-3. PubMed ID: 15499987
[TBL] [Abstract][Full Text] [Related]
76. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.
Niki T; Kohno T; Iba S; Moriya Y; Takahashi Y; Saito M; Maeshima A; Yamada T; Matsuno Y; Fukayama M; Yokota J; Hirohashi S
Am J Pathol; 2002 Mar; 160(3):1129-41. PubMed ID: 11891209
[TBL] [Abstract][Full Text] [Related]
77. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer.
Ikeda K; Sakai K; Yamamoto R; Hareyama H; Tsumura N; Watari H; Shimizu M; Minakami H; Sakuragi N
Int J Gynecol Cancer; 2003; 13(6):776-84. PubMed ID: 14675314
[TBL] [Abstract][Full Text] [Related]
78. Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions.
Legan M; Luzar B; Marolt VF; Cor A
World J Gastroenterol; 2006 Jun; 12(21):3425-9. PubMed ID: 16733863
[TBL] [Abstract][Full Text] [Related]
79. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.
Sakamoto A; Yokoyama Y; Umemoto M; Futagami M; Sakamoto T; Bing X; Mizunuma H
Br J Cancer; 2004 Aug; 91(4):633-8. PubMed ID: 15266333
[TBL] [Abstract][Full Text] [Related]
80. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.
Cho DS; Joo HJ; Oh DK; Kang JH; Kim YS; Lee KB; Kim SJ
Yonsei Med J; 2005 Feb; 46(1):133-40. PubMed ID: 15744816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
